A close relationship between Helicobacter pylori infection and the serum level of CD47 in adults

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Padmanabhan N, Ushijima T, Tan P. How to stomach an epigenetic insult: the gastric cancer epigenome. Nat Rev Gastroenterol Hepatol. 2017;14(8):467–478.
   PubMed Web of Science ®Google Scholar
• Amieva M, Peek RM Jr. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150(1):64–78.
   PubMed Web of Science ®Google Scholar
• Cover TL, Peek RM Jr. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes. 2013;4(6):482–493.
   PubMed Web of Science ®Google Scholar
• Kim GH, Liang PS, Bang SJ, et al. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc. 2016;84(1):18–28.
   PubMed Web of Science ®Google Scholar
• Huang KK, Ramnarayanan K, Zhu F, et al. Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer. Cancer Cell. 2018;33(1):137–150.
   PubMed Web of Science ®Google Scholar
• Ma G, Liu H, Hua Q, et al. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome. Mol Cancer. 2017;16(1):46.
   PubMedGoogle Scholar
• Zhu S, Soutto M, Chen Z, et al. Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells. Oncogene. 2019;38(29):5805–5816.
   PubMed Web of Science ®Google Scholar
• de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–615.
   PubMed Web of Science ®Google Scholar
• Wang F, Meng W, Wang B, et al. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345(2):196–202.
   PubMed Web of Science ®Google Scholar
• Wroblewski LE, Choi E, Petersen C Jr., et al. Targeted mobilization of Lrig1+ gastric epithelial stem cell populations by a carcinogenic Helicobacter pylori type IV secretion system. Proc Natl Acad Sci USA. 2019;116(39):19652–19658.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Tsujimoto H, Matsumura K, et al. CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer. Cancer Med. 2015;4(9):1322–1333.
   PubMed Web of Science ®Google Scholar
• Sudo T, Takahashi Y, Sawada G, et al. Significance of CD47 expression in gastric cancer. Oncol Lett. 2017;14(1):801–809.
   PubMed Web of Science ®Google Scholar
• Abe H, Saito R, Ichimura T, et al. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells. Virchows Arch. 2018;472(4):643–651.
   PubMed Web of Science ®Google Scholar
• Shahan TA, Ziaie Z, Pasco S, et al. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res. 1999;59(18):4584–4590.
   PubMed Web of Science ®Google Scholar
• Mawby WJ, Holmes CH, Anstee DJ, et al. Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem J. 1994;304(2):525–530.
   PubMedGoogle Scholar
• Matozaki T, Murata Y, Okazawa H, et al. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol. 2009;19(2):72–80.
   PubMed Web of Science ®Google Scholar
• Ide K, Wang H, Tahara H, et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA. 2007;104(12):5062–5066.
   PubMed Web of Science ®Google Scholar
• Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells. Science. 2000;288(5473):2051–2054.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138(2):271–285.
   PubMed Web of Science ®Google Scholar
• Makristathis A, Hirschl AM, Mégraud F, et al. Review: diagnosis of Helicobacter pylori infection. Helicobacter. 2019;24 (Suppl 1):e12641.
   PubMedGoogle Scholar
• Best LM, Takwoingi Y, Siddique S, et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018;3(3):CD012080.
   PubMedGoogle Scholar
• Graham DY, Miftahussurur M. Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: a mini review. J Adv Res. 2018;13:51–57.
   PubMed Web of Science ®Google Scholar
• Yang JC, Lin CJ, Wang HL, et al. High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection. Clin Gastroenterol Hepatol. 2015;13(5):895–905.
   PubMed Web of Science ®Google Scholar
• Matlung HL, Szilagyi K, Barclay NA, et al. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer. Immunol Rev. 2017;276(1):145–164.
   PubMed Web of Science ®Google Scholar
• Feng M, Jiang W, Kim BYS, et al. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat Rev Cancer. 2019;19(10):568–586.
   PubMed Web of Science ®Google Scholar
• Ma D, Liu S, Lal B, et al. Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma. Cancer Res. 2019;79(10):2697–2708.
   PubMed Web of Science ®Google Scholar
• Daubon T, Léon C, Clarke K, et al. Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nat Commun. 2019;10(1):1146.
   PubMedGoogle Scholar
• Xu C, Yan M, Sun Y Jr, et al. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter. 2014;19(6):437–442.
   PubMed Web of Science ®Google Scholar
• He C, Yang Z, Cheng D, et al. Helicobacter pylori infection aggravates diet-induced insulin resistance in association with gut microbiota of mice. EBioMedicine. 2016;12:247–254.
   PubMed Web of Science ®Google Scholar
• Budzyński J, Koziński M, Kłopocka M, et al. Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. Clin Res Cardiol. 2014;103(11):855–886.
   PubMed Web of Science ®Google Scholar
• Echizen K, Hirose O, Maeda Y, et al. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. Cancer Sci. 2016;107(4):391–397.
   PubMed Web of Science ®Google Scholar
• Lim SH, Kim N, Kwon JW, et al. Positive association between Helicobacter pylori infection and metabolic syndrome in a Korean population: a Multicenter Nationwide Study. Dig Dis Sci. 2019;64(8):2219–2230.
   PubMed Web of Science ®Google Scholar
• Martí A, Marcos A, Martínez JA. Obesity and immune function relationships. Obes Rev. 2001;2(2):131–140.
   PubMedGoogle Scholar
• Moulin CM, Marguti I, Peron JP, et al. Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metabol. 2009;53(2):183–189.
   PubMedGoogle Scholar
• Roper J, Francois F, Shue PL, et al. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab. 2008;93(6):2350–2357.
   PubMed Web of Science ®Google Scholar
• Kojima Y, Volkmer JP, McKenna K, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536(7614):86–90.
   PubMed Web of Science ®Google Scholar
• Betancur PA, Abraham BJ, Yiu YY, et al. A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer. Nat Commun. 2017;8:14802.
   PubMed Web of Science ®Google Scholar
• Tourani M, Habibzadeh M, Karkhah A, et al. Association of TNF-α but not IL-1β levels with the presence of Helicobacter pylori infection increased the risk of peptic ulcer development. Cytokine. 2018;110:232–236.
   PubMed Web of Science ®Google Scholar
• Sulzbach DE Oliveira HS, Biolchi V, Richardt Medeiros HR, et al. Effect of Helicobacter pylori on NFKB1, p38α and TNF-α mRNA expression levels in human gastric mucosa. Exp Ther Med. 2016;11(6):2365–2372.
   PubMed Web of Science ®Google Scholar
• Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010;10(6):403–414.
   PubMed Web of Science ®Google Scholar
• Kim SS, Ruiz VE, Carroll JD, et al. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett. 2011;305(2):228–238.
   PubMed Web of Science ®Google Scholar
• Maimaitiyiming H, Norman H, Zhou Q, et al. CD47 deficiency protects mice from diet-induced obesity and improves whole body glucose tolerance and insulin sensitivity. Sci Rep. 2015;5:8846.
   PubMed Web of Science ®Google Scholar